[go: up one dir, main page]

ATE240343T1 - Darstellung von esterderivaten von steroiden - Google Patents

Darstellung von esterderivaten von steroiden

Info

Publication number
ATE240343T1
ATE240343T1 AT96912447T AT96912447T ATE240343T1 AT E240343 T1 ATE240343 T1 AT E240343T1 AT 96912447 T AT96912447 T AT 96912447T AT 96912447 T AT96912447 T AT 96912447T AT E240343 T1 ATE240343 T1 AT E240343T1
Authority
AT
Austria
Prior art keywords
steroids
preparation
ester derivatives
norpregn
norprogesterone
Prior art date
Application number
AT96912447T
Other languages
English (en)
Inventor
Fang Li
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Application granted granted Critical
Publication of ATE240343T1 publication Critical patent/ATE240343T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
AT96912447T 1995-10-13 1996-03-20 Darstellung von esterderivaten von steroiden ATE240343T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/542,664 US5710293A (en) 1995-10-13 1995-10-13 Method of preparation of ester derivatives of steroids
PCT/US1996/003991 WO1997013779A1 (en) 1995-10-13 1996-03-20 Preparation of ester derivatives of steroids

Publications (1)

Publication Number Publication Date
ATE240343T1 true ATE240343T1 (de) 2003-05-15

Family

ID=24164784

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96912447T ATE240343T1 (de) 1995-10-13 1996-03-20 Darstellung von esterderivaten von steroiden

Country Status (9)

Country Link
US (1) US5710293A (de)
EP (1) EP0866798B1 (de)
AT (1) ATE240343T1 (de)
CA (1) CA2231185C (de)
DE (1) DE69628192T2 (de)
DK (1) DK0866798T3 (de)
ES (1) ES2198482T3 (de)
PT (1) PT866798E (de)
WO (1) WO1997013779A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608220B1 (en) * 1994-10-27 2003-08-19 Pharmacia & Upjohn Company Conversion of bisnoralcohol to bisnoraldehyde

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3383394A (en) * 1965-08-30 1968-05-14 Schering Corp Novel 17-acylating process and products thereof
DE1543245C3 (de) * 1965-11-26 1974-07-18 Merck Patent Gmbh, 6100 Darmstadt 16-Methy len-19-norprogesteronderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
GB1260465A (en) * 1968-01-29 1972-01-19 Glaxo Lab Ltd 11beta-CHLORO-19-NOR-STEROIDS
DE2246462C3 (de) * 1972-09-21 1981-07-23 Schering Ag Berlin Und Bergkamen, 1000 Berlin 15 α , 16 α -Methylen-4-pregnene, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE2803660A1 (de) * 1978-01-25 1979-07-26 Schering Ag Neue in 17-position substituierte steroide der pregnanreihe, ihre herstellung und verwendung
US5223492A (en) * 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them

Also Published As

Publication number Publication date
DK0866798T3 (da) 2003-09-01
US5710293A (en) 1998-01-20
WO1997013779A1 (en) 1997-04-17
EP0866798A1 (de) 1998-09-30
PT866798E (pt) 2003-09-30
CA2231185A1 (en) 1997-04-17
DE69628192D1 (de) 2003-06-18
DE69628192T2 (de) 2004-03-25
EP0866798A4 (de) 1998-12-02
EP0866798B1 (de) 2003-05-14
CA2231185C (en) 2006-10-17
ES2198482T3 (es) 2004-02-01

Similar Documents

Publication Publication Date Title
MX9600177A (es) Montaje de panel de anchura ajustable.
FI974448A7 (fi) Androstaani- ja pregnaanisarjan neuroaktiiviset steroidit
DE69837041D1 (de) Verfahren und mikroorganism zur herstellung von purin-nukleosiden durch fermentation
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
ATA363284A (de) Schalldaemmende verbundplatte und verfahren zu ihrer herstellung
NL300017I1 (nl) Gesubstitueerde androsta-1,4-dieen-3,17-dionen, alsmede farmaceutische preparaten die dergelijke verbindingen bevatten.
NL300196I1 (nl) Pregna-1,4-dieen-3,20-dion-16-17-acetaal-21 esters, werkwijze voor een bereiding, preparaat.
DE69721399D1 (de) Verfahren für die herstellung von zementplatten
NO971568L (no) Analoger av keratinocyttvekstfaktor
FI884087A7 (fi) Menetelmä androsta-1,4-dieeni-3,17-dionin metyleenijohdannaisten val mistamiseksi
DE69818278D1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung
DE60203013D1 (de) 17alfa, 21-dihydroxypregnene esters als antiandrogene wirkstoffe
DK0776904T3 (da) Fremgangsmåde til fremstilling af steroidderivatketal
NO20023276D0 (no) Fremgangsmåte til å fremstille betulinsyre
DE3779881D1 (de) Steroid-derivate und verfahren zu ihrer herstellung.
ATE240343T1 (de) Darstellung von esterderivaten von steroiden
DE69620474D1 (de) Mikrobielle 11alpha-hydroxylierung von steroiden
ATA212097A (de) Verfahren zur herstellung von vorgefertigten wandelementen für die errichtung von bauwerken sowie vorrichtung zur durchführung dieses verfahrens
DE69419816D1 (de) Beschickungsanlage für die Herstellung von gebrauchsfertigem Beton
SU1240038A1 (ru) 3-оксиэстра-1,3,5-триен-17-гидразон, обладающий гормональной и противоопухолевой активностью
FI973215L (fi) Menetelmä pelkistävien sokereiden hajottamiseksi emäksisen hapetuksen avulla ja näin saadut tuotteet
EP0809500A4 (de) Neue glucocorticoidantwort-elemente
DE69608899D1 (de) Verfahren für die herstellung und die isolierung von cyclopropancarbonitril
DE69822870D1 (de) Verfahren zur desmethylierung von erythromycinen und deren derivaten
CA2188981A1 (en) Isomerisation of equilin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0866798

Country of ref document: EP